Steven Perrin

Person

Newbury, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Targeting of endoplasmic reticulum dysfunction and protein folding...
- Patent number 12,157,728
- Issue date Dec 3, 2024
- ALS Therapy Development Institute
- Alan Gill
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Targeting of endoplasmic reticulum dysfunction and protein folding...
- Patent number 11,708,349
- Issue date Jul 25, 2023
- ALS Therapy Development Institute
- Alan Gill
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD40L antibodies and methods for treating CD40L-related diseas...
- Patent number 11,692,040
- Issue date Jul 4, 2023
- ALS Therapy Development Institute
- John M. Lincecum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Copper complexes for treatment of neurodegenerative disorders
- Patent number 11,660,324
- Issue date May 30, 2023
- ALS Therapy Development Institute
- Steven Perrin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD40L antibodies
- Patent number 11,014,990
- Issue date May 25, 2021
- ALS Therapy Development Institute
- John M. Lincecum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating a CD40L associated disease or disorder by admin...
- Patent number 10,683,356
- Issue date Jun 16, 2020
- ALS Therapy Development Institute
- John M. Lincecum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD40L antibodies
- Patent number 10,106,618
- Issue date Oct 23, 2018
- ALS Therapy Development Institute
- John M. Lincecum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treating neurological disorders
- Patent number 9,775,899
- Issue date Oct 3, 2017
- Biogen MA Inc.
- Linda C. Burkly
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for the treatment of neurodegenerative diseases
- Patent number 9,044,459
- Issue date Jun 2, 2015
- ALS Therapy Development Institute
- Steven Perrin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Targeting of T-lymphocytes to treat amyotrophic lateral sclerosis
- Patent number 8,946,301
- Issue date Feb 3, 2015
- ALS Therapy Development Institute
- Steven Perrin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Targeting of CD8+ T-lymphocytes to treat neurodegenerative diseases
- Patent number 8,673,308
- Issue date Mar 18, 2014
- ALS Therapy Development Institute
- Steven Perrin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for the treatment of neurodegenerative diseases
- Patent number 8,435,514
- Issue date May 7, 2013
- ALS Therapy Development Institute
- Steven Perrin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ANTI-CD40L ANTIBODIES AND METHODS FOR TREATING CD40L-RELATED DISEAS...
- Publication number 20240043549
- Publication date Feb 8, 2024
- ALS Therapy Development Institute
- John M. Lincecum
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COPPER COMPLEXES FOR TREATMENT OF NEURODEGENERATIVE DISORDERS
- Publication number 20240016879
- Publication date Jan 18, 2024
- ALS Therapy Development Institute
- Steven Perrin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TARGETING OF ENDOPLASMIC RETICULUM DYSFUNCTION AND PROTEIN FOLDING...
- Publication number 20230382890
- Publication date Nov 30, 2023
- ALS Therapy Development Institute
- Alan GILL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD40L ANTIBODIES AND METHODS FOR TREATING CD40L-RELATED DISEAS...
- Publication number 20210269538
- Publication date Sep 2, 2021
- ALS Therapy Development Institute
- John M. Lincecum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COPPER COMPLEXES FOR TREATMENT OF NEURODEGENERATIVE DISORDERS
- Publication number 20210038676
- Publication date Feb 11, 2021
- ALS Therapy Development Institute
- Steven Perrin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TARGETING OF ENDOPLASMIC RETICULUM DYSFUNCTION AND PROTEIN FOLDING...
- Publication number 20210009558
- Publication date Jan 14, 2021
- ALS Therapy Development Institute
- Alan GILL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD40L ANTIBODIES AND METHODS FOR TREATING CD40L-RELATED DISEAS...
- Publication number 20200277391
- Publication date Sep 3, 2020
- ALS Therapy Development Institute
- John M. Lincecum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD40L ANTIBODIES AND METHODS FOR TREATING CD40L-RELATED DISEAS...
- Publication number 20190092868
- Publication date Mar 28, 2019
- ALS Therapy Development Institute
- John M. Lincecum
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CD40L ANTIBODIES AND METHODS FOR TREATING CD40L-RELATED DISEAS...
- Publication number 20170342158
- Publication date Nov 30, 2017
- ALS Therapy Development Institute
- John M. Lincecum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Measurement Of ALS Progression Based On Kinetic Data
- Publication number 20170231558
- Publication date Aug 17, 2017
- ALS Therapy Development Institute
- Alan Gill
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method for the Treatment of Neurodegenerative Diseases
- Publication number 20130295092
- Publication date Nov 7, 2013
- Steven Perrin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TARGETING OF T-LYMPHOCYTES TO TREAT AMYOTROPHIC LATERAL SCLEROSIS
- Publication number 20130150454
- Publication date Jun 13, 2013
- ALS Therapy Development Institute
- Steven Perrin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATING NEUROLOGICAL DISORDERS
- Publication number 20130095175
- Publication date Apr 18, 2013
- Biogen Idec MA Inc.
- LINDA C. BURKLY
- G01 - MEASURING TESTING
Information Patent Application
TARGETING OF CD8+ T-LYMPHOCYTES TO TREAT NEURODEGENERATIVE DISEASES
- Publication number 20120237505
- Publication date Sep 20, 2012
- ALS Therapy Development Institute
- Steven Perrin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATING NEUROLOGICAL DISORDERS
- Publication number 20120183542
- Publication date Jul 19, 2012
- Biogen Idec MA Inc.
- Linda C. Burkly
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method for the Treatment of Neurodegenerative Diseases
- Publication number 20110293612
- Publication date Dec 1, 2011
- ALS Therapy Development Institute
- Steven Perrin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATING NEUROLOGICAL DISORDERS
- Publication number 20090124993
- Publication date May 14, 2009
- Linda C. Burkly
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Steven Perrin

Person

Patents Grantslast 30 patents

Targeting of endoplasmic reticulum dysfunction and protein folding...

Targeting of endoplasmic reticulum dysfunction and protein folding...

Anti-CD40L antibodies and methods for treating CD40L-related diseas...

Copper complexes for treatment of neurodegenerative disorders

Anti-CD40L antibodies

Methods of treating a CD40L associated disease or disorder by admin...

Anti-CD40L antibodies

Treating neurological disorders

Method for the treatment of neurodegenerative diseases

Targeting of T-lymphocytes to treat amyotrophic lateral sclerosis

Targeting of CD8+ T-lymphocytes to treat neurodegenerative diseases

Method for the treatment of neurodegenerative diseases

Patents Applicationslast 30 patents

ANTI-CD40L ANTIBODIES AND METHODS FOR TREATING CD40L-RELATED DISEAS...

COPPER COMPLEXES FOR TREATMENT OF NEURODEGENERATIVE DISORDERS

TARGETING OF ENDOPLASMIC RETICULUM DYSFUNCTION AND PROTEIN FOLDING...

ANTI-CD40L ANTIBODIES AND METHODS FOR TREATING CD40L-RELATED DISEAS...

COPPER COMPLEXES FOR TREATMENT OF NEURODEGENERATIVE DISORDERS

TARGETING OF ENDOPLASMIC RETICULUM DYSFUNCTION AND PROTEIN FOLDING...

ANTI-CD40L ANTIBODIES AND METHODS FOR TREATING CD40L-RELATED DISEAS...

ANTI-CD40L ANTIBODIES AND METHODS FOR TREATING CD40L-RELATED DISEAS...

ANTI-CD40L ANTIBODIES AND METHODS FOR TREATING CD40L-RELATED DISEAS...

Measurement Of ALS Progression Based On Kinetic Data

Method for the Treatment of Neurodegenerative Diseases

TARGETING OF T-LYMPHOCYTES TO TREAT AMYOTROPHIC LATERAL SCLEROSIS

TREATING NEUROLOGICAL DISORDERS

TARGETING OF CD8+ T-LYMPHOCYTES TO TREAT NEURODEGENERATIVE DISEASES

TREATING NEUROLOGICAL DISORDERS

Method for the Treatment of Neurodegenerative Diseases

TREATING NEUROLOGICAL DISORDERS